✦ LIBER ✦

Peritoneal minimal residual disease in colorectal cancer: mechanisms, prevention, and treatment

✍ Scribed by Wim P Ceelen; Marc E Bracke

Book ID: 117784906
Publisher: The Lancet
Year: 2009
Tongue: English
Weight: 221 KB
Volume: 10
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(08)70335-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular Mechanisms of Cancer || Dorman

Molecular Mechanisms of Cancer || Dormancy and Minimal Residual Disease

✍ , 📂 Article 📅 2007 🏛 Springer Netherlands ⚖ 126 KB

Treatment and prevention of peritoneal c

Treatment and prevention of peritoneal carcinomatosis from colorectal cancer

✍ Pocard, Marc; Elias, Dominique M. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 283 KB

Minimal Residual Disease in Head and Nec

Minimal Residual Disease in Head and Neck Cancer

✍ Hans J. Gath; Ruud H. Brakenhoff 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 90 KB

Minimal residual disease and circulating

Minimal residual disease and circulating tumor cells in breast cancer

✍ Michail Ignatiadis; Monica Reinholz 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 159 KB

Minimal residual disease testing in hema

Minimal residual disease testing in hematologic malignancies and solid cancer

✍ Ben Lassoued, Amin; Nivaggioni, Vanessa; Gabert, Jean 📂 Article 📅 2014 🏛 Expert Reviews 🌐 English ⚖ 462 KB

Prognostic significance of peritoneal mi

Prognostic significance of peritoneal minimal residual disease in gastric cancer detected by reverse transcription–polymerase chain reaction

✍ K. Oyama; M. Terashima; A. Takagane; C. Maesawa 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

## Abstract ## Background A sensitive method for detecting minimal residual disease in the peritoneal cavity by quantifying carcinoembryonic antigen (CEA) mRNA using real-time quantitative reverse transcription–polymerase chain reaction (RQ-RT–PCR) was developed. The clinical value of the method f